Atropine Sulfate

6 trials SOphthalmology & ENT

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

6 Completed trials

6 Sponsors

8 Countries

Phase III

Phase II

Phase IV

Phase I (FiH)

Phase III: 2 Phase II: 1 Phase IV: 2 Phase I (FiH): 1

Indications tested

Myopia 1 Retinitis pigmentosa 1

Sponsors using this IMP

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 eyeDNA Therapeutics 1 Hospital Clinico San Carlos 1 Medical Center - University Of Freiburg 1 Ocumension (Hong Kong) Ltd. 1 Pharma Stulln GmbH 1

All trials

6 total

MAD Ended

2024-516379-34-00 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
A phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine… Ended

2024-516315-24-00 Phase III 5 countries Ocumension (Hong Kong) Ltd.
Postmarketing Parallel Randomized Clinical Trial to Determine the Efficacy and Safety of Atropine and DIMS Lenses in the Control of Myopia i… Ended

2024-514651-15-00 Phase IV 1 country Hospital Clinico San Carlos
Low-dose AtropIne for Myopia control in children Ended

2024-513091-17-00 Phase III 1 country Medical Center - University Of Freiburg
A randomized, double-blind, placebo-controlled dose-finding study of 0.05%, 0.025%, 0.01% and 0.005% atropine eye drops to inhibit myopia pr… Ended

2024-516758-23-00 Phase II 1 country Pharma Stulln GmbH
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in th… Ended

2024-511687-90-00 Phase I (FiH) 1 country eyeDNA Therapeutics

Showing 1–6 of 6 trials

← All drugs A–Z